Multiple Organ Dysfunction Syndrome After Trauma: Update 2017

  • Andrea DeGasperiEmail author
  • Lucio Bucci
  • Bianca M. Wahlen


Trauma is still the major cause of death and severe disabilities both in developing and industrialized countries. Severe trauma promotes a hyperinflammatory condition able to lead to a condition of organ(s) dysfunction known as multiple organ dysfunction syndrome (MODS), which in a continuum might end to multiple organ failure (MOF) and in worst cases death. Opposite inflammatory and anti-inflammatory responses are simultaneously present after trauma, leading to (multiple) organ dysfunction(s). The definition of MOF is still a matter of debate, and scores to grade its severity (MODS, SOFA, Denver score) are used with quite different results according to their sensibility and specificity. Harmonization of the scores and shared definitions appears mandatory to overcome this problem. Risk factors for MOF are male sex, age, obesity, severity of injury, units of red blood cells (RBCs) transfused within the first 12 h, and acidosis. As for infections, in trauma innate and adaptive responses are triggered by alarmins and damage-associated molecular patterns (DAMPs), recognized by components of innate and acquired immunity (mainly Toll-like receptors, TLRs): TLRs are able to transduce signals in response to alarmins and DAMPs and to activate several signal pathways, making these molecules the possible link between SIRS, inflammation, and trauma. Prevention of major dysfunctions of the cardiovascular, respiratory, and renal systems remains the mainstay strategy, mainly based on early, adequate, aggressive supportive measures.


  1. 1.
    Offner PJ, Moore EE. Risk factors for MOF and patter of organ failure following severe trauma, Chap 4. In: Baue AE, Faist E, Fry DE, editors. Multiple organ failure. New York: Springer; 2000. p. 30–43.CrossRefGoogle Scholar
  2. 2.
    Baue AE. Hystory of MOF and definition of organ failure, Chap 1. In: Baue AE, Faist E, Fry DE, editors. Multiple organ failure. New York: Springer; 2000. p. 3–13.CrossRefGoogle Scholar
  3. 3.
    Fry DE. MODS: an introduction, Chap 3. In: Deitch EA, Vincent J-L, Windsor A, editors. Sepsis and multiple organ dysfunction. Philadelphia: WB Saunders; 2002. p. 19–25.Google Scholar
  4. 4.
    Moore FA, Moore EE. MODS following trauma, Chap 4. In: Deitch EA, Vincent J-L, Windsor A, editors. Sepsis and multiple organ dysfunction. Philadelphia: WB Saunders; 2002. p. 26–33.Google Scholar
  5. 5.
    Baue AE. MOF, MODS, and SIRS: what is in a name or an acronym? Shock. 2006;25:438–49.CrossRefGoogle Scholar
  6. 6.
    Sauaia A, Moore FA, Moore EE. Postinjury inflammation and organ dysfunction. Crit Care Clin. 2017;33:167–91.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, et al. A genomic storm in critically injured humans. J Exp Med. 2011;208:2581–90.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Hezeldine J, Naumann DN, Toman E, Davies D, Bishop JRB, Su Z, et al. Prehospital immune response and development of multiple organ dysfunction syndrome following traumatic injury: a prospective cohort study. PLOS Med. 2017;
  9. 9.
    Frohlich M, Wafaisade A, Mansuri A, Koenen P, Probst C Maegele M, et al. Which score should be used for posttraumatic multiple organ failure? Comparison of the MODS, DENVER and SOFA scores. Scand J Trauma Resusc Emerg Med. 2016;24:130. Scholar
  10. 10.
    Hutchings L, Watkinson P, Young JD, Willett K. Defining multiple organ failure after major trauma: a comparison of the Denver, Sequential Organ Failure Assessment, and Marshall scoring systems. J Trauma Acute Care Surg. 2017;82:534–41.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Rendy L, Sapan HB, Kalesaran LTB. Multiple organ dysfunction syndrome prediction score in multi trauma patients. Int J Surg Open. 2017;8:1–6.CrossRefGoogle Scholar
  12. 12.
    Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007;81:1–5.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464(7285):104–7.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Cohen MJ, Brohi K, Calfee CS, et al. Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion. Crit Care. 2009;13:R174.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Manson J, Thiemermann C, Brohi K. Trauma alarmins as activators of damage-induced inflammation. Br J Surg. 2012;99(S1):12–20.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Weinbaum S, Tarbell JM, Damiano ER. The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng. 2007;9:121–67.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Noel P, Cashen S, Patel B. Trauma-induced coagulopathy: from biology to therapy. Semin Hematol. 2013;50:259–69.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Ostrowski SR, Johannson P. Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy. J Trauma Acute Care Surg. 2012;73:60–6.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Pierce A, Pittet J-F. Inflammatory response to trauma: implications for coagulation and resuscitation. Curr Opin Anesthesiol. 2014;27(2):246–52.CrossRefGoogle Scholar
  20. 20.
    Johansson PI, Stensballe J, Ostrowski SR. Shock induced endotheliopathy (SHINE) in acute critical illness – a unifying pathophysiologic mechanism. Crit Care. 2017;21:25.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Asenhnoune K, Balogh Z, Citerio G, Cap A, Billiar T, Stocchetti N, et al. The research agenda for trauma critical care. Intens Care Med.
  22. 22.
    Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2013;(2):CD000567.Google Scholar
  23. 23.
    Brinck T, Handolin L, Lefering R. The effect of evolving fluid resuscitation on the outcome of severely injured patients: an 8-year experience at a tertiary trauma center. Scand J Surg. 2016;105:109–16. Scholar
  24. 24.
    Simmons JW, Powell MF. Acute traumatic coagulopathy: pathophysiology and resuscitation. Br J Anaesth. 2016;117:iii31–43. Scholar
  25. 25.
    Napolitano LM, Kurek S, Luchette FA, et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med. 2009;37(12):3124–57.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016;20:100. Scholar
  27. 27.
    Shakur H, Roberts I, CRASH-2 trial Collaborators, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23–32. Scholar
  28. 28.
    Moore EE, Moore HB, Gonzalez E, et al. Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient. Transfusion. 2016;56(Suppl 2):S110–4. Scholar
  29. 29.
    Curry N, Rourke C, Davenport R, et al. Early cryoprecipitate for major haemorrhage in trauma: a randomised controlled feasibility trial. Br J Anaesth. 2015;115:76–83. Scholar
  30. 30.
    Gonzalez E, Moore EE, Moore HB, et al. Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays. Ann Surg. 2016;263:1051–9. Scholar
  31. 31.
    Oyeniyi BT, Fox EE, Scerbo M, et al. Trends in 1029 trauma deaths at a level 1 trauma center: impact of a bleeding control bundle of care. Injury. 2017;48:5–12.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    National Institute for Clinical Excellence (NICE). Major trauma assessment and initial management guidelines. 2016.
  33. 33.
    Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313:471–82. Scholar
  34. 34.
    ARDS network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. the acute respiratory distress syndrome network. N Engl J Med. 2000;342:1301–8.Google Scholar
  35. 35.
    Petrucci N, De Feo C. Lung protective ventilation strategy for the acute respiratory distress syndrome. Cochrane Database Syst Rev. 2013;(2):CD003844.Google Scholar
  36. 36.
    Roquilly A, Cinotti R, Jaber S, et al. Implementation of an evidence based extubation readiness bundle in 499 brain-injured patients. A before-after evaluation of a quality improvement project. Am J Respir Crit Care Med. 2013;188:958–66. Scholar
  37. 37.
    Offner PJ, Moore EE, Ciesla D. The adrenal response after severe trauma. Am J Surg. 2002;184(6):649–53.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Islam NM, Bradley BA, Ceredig R. Sterile post-traumatic immunosuppression. Clin Transl Immunol. 2016;5:e77. Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Andrea DeGasperi
    • 1
    Email author
  • Lucio Bucci
    • 2
  • Bianca M. Wahlen
    • 3
  1. 1.2° Servizio Anestesia e RianimazioneOspedale Niguarda Ca’ GrandaMilanItaly
  2. 2.1° Servizio Anestesia e RianimazioneOspedale Niguarda Ca’ GrandaMilanItaly
  3. 3.Department of Trauma SurgeryHamad General HospitalDohaQatar

Personalised recommendations